Ramesh Hariharan
Lakeshore Hospital & Research Center, Cochin, Kerala, India.
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S90-6. doi: 10.1016/j.jceh.2014.07.002. Epub 2014 Aug 27.
Hepatocellular Carcinoma (HCC) continues to present major challenges in management, which is further complicated by the presence of associated chronic liver disease. Key issues in surgical resection of HCC include the site, size, and number of lesions, the severity of the chronic liver disease, and the size of the functional liver remnant. De novo HCC in the absence of chronic liver disease can be treated by major liver resection with little risk of postoperative liver failure. Liver resection can also be used a bridge to liver transplantation as it affords the possibility of determining the pathologic grade of the tumortumor and its invasiveness, and thereby the prognosis. This review summarizes the current treatment approaches to surgical resection for HCC.
肝细胞癌(HCC)在治疗方面仍然面临重大挑战,而相关慢性肝病的存在使情况更加复杂。HCC手术切除的关键问题包括病变的部位、大小和数量、慢性肝病的严重程度以及功能性肝残余量的大小。在没有慢性肝病的情况下发生的新发HCC可以通过大范围肝切除进行治疗,术后发生肝衰竭的风险很小。肝切除也可作为肝移植的桥梁,因为它能够确定肿瘤的病理分级及其侵袭性,从而判断预后。本综述总结了目前HCC手术切除的治疗方法。